Schedule 13G ownership disclosure

Graf Acquisition Corp. IV

Security class unavailable · CUSIP: 384272100

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,124,431
Percent of class
5.2400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-22-001003
Form type
SC 13G/A
Filer
NKGen Biotech, Inc.
CIK
CIK 1845459
Filed
Feb 03, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub